
Hypergammaglobulinemia is the increase in the production of immunoglobulins by B Lymphocytes in response to different stimuli. It is associated with several clinical-pathological states. Objective: To describe the usefulness of the detection of hypergammaglobulinemia, its relationship with different clinical-pathological states, and the role of the laboratory. Materials and methods: A bibliographic search was carried out in Pubmed and Google Scholar. Results showed that hypergammaglobulinemia is detected through different techniques, such as protein electrophoresis for a qualitative analysis of immunoglobulins that migrate in the gamma sector, immunofixation or immunoelectrophoresis to classify it as monoclonal or polyclonal, and quantitative techniques to determine concentrations of the different classes. Results also showed that polyclonal hypergammaglobulinemia occurs in chronic viral infections, autoimmune pathologies and inborn errors of immunity, while monoclonal hypergammaglobulinemia is associated with malignant neoplasms. Conclusion: Hypergammaglobulinemia can be identified through different laboratory techniques and, thanks to this, it can contribute to the diagnosis of the patient and the differentiation with other pathological clinical states.
Introduction: Meningitis is an infection of the central nervous system, which, in 80% of the cases, occurs in childhood. Due to its association with high morbimortality, it is considered an infectological emergency. The main etiologies are viral and bacterial. The chemical and cytological analysis of cerebrospinal fluid is key to orient the etiological diagnosis and provide proper treatment. There is evidence that serum C-reactive protein could contribute. Objective: To analyze the utility of cerebrospinal fluid parameters and C-reactive protein in the discrimination of viral and bacterial meningitis in pediatric patients. Materials and methods: The study was observational, analytical, cross-sectional and retrospective. Clinical records of children with diagnosis of meningitis with confirmed etiological agent assessed from January 2016 to December 2019 in the General de Niños Pedro de Elizalde Hospital (Buenos Aires, Argentina) were revised. Results: A total of 101 records were included. Total proteins, cell counts and C-reactive protein were significantly higher in patients with bacterial meningitis, whereas glucose was lower. No difference was found in lactate level. In establishing bacterial etiology, serum C-reactive protein level above 34.77 mg/L showed a sensitivity of 100%, a specificity of 92% and a negative predictive value of 100%; for total proteins, a cut-off point of 0.52 g/L showed the best sensitivity, while for glucose a cut-off point of 55 mg/ dL had the highest specificity. Conclusion: Cerebrospinal fluid protein and glucose levels were the best parameters to discriminate between these etiologies. Serum C-reactive protein showed very good performance, although further studies in pediatric patients are needed to establish its utility.
Objectives: To analyze telomere length (LT) as a biomarker of risk and progression of metabolic diseases and to evaluate the TL according to the number of metabolic alterations and environmental risk factors. Materials and Methods: We performed a cross-sectional study of 1006 individuals categorized into: metabolically healthy individuals with obesity (OMS); obesity and metabolic syndrome (OSM) and a normal weight control group (NP). Biochemical-clinical and anthropometric determinations were made and the presence of lifestyle risk factors and pre-existing diseases were self-reported. The absolute LT in peripheral blood DNA was determined by quantitative PCR. Statistical analysis was performed with SPSS v20.0 with p<0.05. Results: A lower TL was associated with the presence of metabolic syndrome abnormalities and the progressive increase in the number of components (p<0.001). The OMS individuals presented a significantly lower TL than the NP individuals (p=0.034) and higher than the OSM ones (p=0.004). The lowest LT was associated with the highest number of years of smoking (p=0.003). Finally, the lowest tercile of TL was associated with a higher risk of presenting increased waist circumference (OR=2.13; p<0.001), high triglycerides (OR=1.68; p=0.034), dyslipidemia (OR=1.86; p= 0.039), obesity (OR=2.41; p<0.001) and metabolic syndrome (OR=2.12; p<0.001). Conclusion: LT may be a useful biomarker of risk and progression of metabolic diseases such as cardiovascular disease and type 2 diabetes.
Over the last years, there has been a rapid expansion on the use of analytical systems to determine biologicalmagnitudes outside the centralized laboratory (POC: point-of-care). These devices, which provide useful and quick information for clinical decision-making, should be considered an extension of the laboratory as they guarantee quality at all stages of the process. During the COVID-19 pandemic, they were fundamental in the detection and monitoring of the infection. The proper installation and use of these systems is a concern to regulatory bodies, reflected in their publication of guides, recommendations and regulations. Frequently, they are perceived as a threat by clinical laboratory services and profesional biochemists. Nevertheless, the experience in diverse countries of the world shows the opposite; the clinical laboratory has professionals trained enough to manage them and ensure their qualified administration. It is important to be aware of the fact that the implementation of point-of-care programs and the improvement in response times contribute to better patient care and attention, being the biochemists the ones responsible for quality assurance, guaranteeing the patients’ safety.